In this free webinar, learn about the various type of registries
and what differentiates them. Attendees will be able to identify
the right type of data for their needs and see what types of
questions can be answered with registry data at various stages in
drug development. The featured speakers will also discuss the
application of scientific methods and analysis to transform
registry data into usable real-world evidence.
TORONTO, May 22, 2024
/PRNewswire-PRWeb/ -- Discover an informative webinar that focuses
on the evolving role of registry data in product development,
approval and post-marketing value demonstration, as well as the
advantages they offer.
Register for this webinar to gain insights
into how RWE and RWD from registries enhance clinical development,
approval and post-marketing analyses, particularly for rare
diseases.
The use of real-world evidence (RWE) in drug development has
been fueled by the increased acceptance of RWE by stakeholders such
as regulatory agencies, health technology assessment bodies and
payers, as well as the plethora of real-world data (RWD)
sources.
Protocolized disease registries are purpose-built for research,
making them one of the most clinically rich sources of RWD.
Registries allow the collection of fit-for-purpose data and are an
acknowledged source for observational RWE generation, especially in
rare diseases where a small number of patients are distributed
across broad geographies.
Registries are most often used to fulfill post-approval safety
commitments, to monitor or compare treatment patterns and
effectiveness outcomes in the real world and to describe the
natural history of diseases. In this webinar, the speakers will
focus on the following topics:
- The type of RWD that can be collected in registries
- How RWD can be used to conduct nested, customized
registry-based studies
- Within one registry, how can it be ensured that data are
collected consistently across patients, practice settings,
geography and time?
- Is there an existing registry that collects the required data
or is a bespoke registry required?
- What do regulators say about using RWD from registries to
inform their decision-making?
- Can registry data be used and linked to other data
sources?
- How can you go from data to actionable insights?
Registries also offer unique and rich data solutions to provide
differentiated insights throughout the drug development process
from identifying unmet needs and market potential to optimizing
clinical trial design, contextualizing safety outcomes and serving
as external control arms to supporting regulatory requirements and
differentiation in therapeutic effectiveness.
The growing demand for regulatory-grade RWD provides exciting
opportunities for researchers seeking rich clinical data to fill
RWD gaps inherent to electronic medical records (EMRs) and payer
claims. Yet, this new landscape has to be carefully navigated to
ensure the right investment is made.
Register for this webinar to gain insights into how RWE and RWD
from registries enhance clinical development, approval and
post-marketing analyses, particularly for rare diseases.
Join experts from the PPD clinical research business of Thermo
Fisher Scientific, Peter Wahl, Vice
President and Global Head of Scientific Affairs, CorEvitas;
Heather Litman, PhD, Vice President
of Biostatistics, CorEvitas; Delphinie Saragoussi, Executive
Director, Real-World Evidence, Epidemiology and Scientific Affairs,
Evidera; Nahila Justo, Executive
Director, RWE Integrated Solutions, Evidera; and Javier Cid, Senior Research Scientist, Data
Analytics, Evidera, for the live webinar on Thursday, June 6, 2024, at 10am EDT (3pm
BST/UK).
For more information, or to register for this event, visit
Registries: Supercharging Real-World Evidence for Drug Development
and Approval.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading
provider of educational webinars and digital content to the global
life science, food, healthcare and medical device communities.
Every year, thousands of industry practitioners (from
pharmaceutical, biotechnology, food, healthcare and medical device
companies, private & academic research institutions, healthcare
centers, etc.) turn to Xtalks for access to quality content. Xtalks
helps professionals stay current with industry developments,
regulations and jobs. Xtalks webinars also provide perspectives on
key issues from top industry thought leaders and service
providers.
To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit
https://xtalks.com/why-host-a-webinar/
Media Contact
Soumya Shashikumar, Xtalks, +1
(416) 977-6555 x371, skumar@xtalks.com, https://xtalks.com
View original content to download
multimedia:https://www.prweb.com/releases/registries-supercharging-real-world-evidence-for-drug-development-and-approval-upcoming-webinar-hosted-by-xtalks-302152448.html
SOURCE Xtalks